Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
296 HER2-specific highly scalable CAR NK cell (anti-HER2-CAR SNK02) exhibits a significantly enhanced antitumor activity against HER2-expressing tumors as an off-the-shelf allogeneic immune cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
